Precision increases in importance as doses decrease
For a drug to be approved for the pregnant population, it must go through rigorous testing with that population, and that has not yet happened for semaglutide or other GLP-1 (glucagon-like peptide 1) agonists, says Carrie Burns , MD, a board-certified endocrinologist and director of diabetes in pregnancy at Penn Medicine in Philadelphia
Ozempic and Wegovy use semaglutide, a GLP-1 medication
Weeks 13 and beyond (1.0 to 2.4 mg maintenance) Once you reach your maintenance dose, your body has adapted and eating patterns stabilize
Semaglutide for people without diabetes While semaglutide injection Wegovy is FDA approved for weight loss in people with and without diabetes, Ozempic and Rybelsus are not specifically cleared for weight loss use
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have shown promise in promoting WL